Merck & Co., Inc. (MRK) Stock Price Today
Aura AI Summary
Key Stats
- $369.73BMarket Cap
- -Volume
- HealthSector
- $156.4352W High
- $77.6052W Low
- -Typical Hold Time
- $416.50BEnterprise Value
- 2.3%Div Yield
- -Trading Activity
Track Merck & Co., Inc. (MRK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Merck & Co., Inc. has traded between a low of $77.6 and a high of $156.43, highlighting its annual price range. Buy and sell Merck & Co., Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Most Recent News
Nvidia's 70% growth forecast reflects supply limits, but actual demand is even stronger.
Nvidia projects a 70% growth rate, which the company says is capped by supply constraints rather than weak demand. This indicates that the market demand for Nvidia's products is actually stronger than the forecast suggests. The supply ceiling could l...
Trump administration backs OpenAI's use of copyrighted material for AI training in lawsuit by NYT
The Trump administration submitted a 20-page brief defending OpenAI's use of copyrighted works to train its AI models in a lawsuit filed by The New York Times. The brief argues that maintaining U.S. leadership in AI development is crucial and that re...
Resideo CEO buys 15,000 shares at $20.46, signaling confidence in the company.
Resideo's CEO, Thomas Surran, purchased 15,000 shares of the company at a price of $20.46 per share. This insider buying often indicates confidence in the company's future prospects. Investors may view this move as a positive signal about Resideo's g...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.